Skip to main content
SpringerLink
Log in

Alendronic acid 10 mg/day regimen increases CV risk

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lu PY, Hsieh CF, Tsai YW, Huang WF.Alendronate and Raloxifene Use Related to Cardiovascular Diseases: Differentiation by Different Dosing Regimens of Alendronate. Clinical Therapeutics: [7 pages], 15 Aug 2011. Available from: URL: http://dx.doi.org/10.1016/j.clinthera.2011.07.012

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid 10 mg/day regimen increases CV risk. React. Wkly. 1368, 4 (2011). https://doi.org/10.2165/00128415-201113680-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113680-00010

Keywords

Search

Navigation